News
As of Thursday afternoon, joint security forces at the Atari checkpoint intercepted a vehicle transporting 72 jerricans of ...
While Gilead Sciences' HIV prevention drug lenacapavir got approved by the US Food and Drug Administration (FDA), its made- ...
The Food and Drug Administration approved a new vaccine to prevent HIV infection, lenacapavir, a long-acting injection, which ...
Spread This NewsBy Lauran Neergaard I Associated Press THE U.S. has approved the world’s only twice-a-year shot to prevent ...
The U.S. Food and Drug Administration has approved a groundbreaking HIV prevention shot that only needs to be taken twice a year. Medical experts are calling it one of the most significant ...
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
10h
HealthDay on MSNFDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV RiskThe U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as ...
10h
Everyday Health on MSNFDA Approves a ‘Game-Changing’ Twice-a-Year HIV Prevention ShotThe new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or every-other-month injections.
The US Food and Drug Administration (FDA) has approved a new shot to prevent HIV, offering a long-acting alternative to daily ...
The US Food and Drug Administration (FDA) on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents at high risk of ...
The United States Food and Drug Administration, FDA, has approved a new long-acting injectable drug, Lenacapavir, for the ...
The United States Food and Drug Administration (FDA) has approved Lenacapavir (LEN), a long-acting injectable antiretroviral hailed as a breakthrough in HIV prevention. Experts in India have welcomed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results